Navigation Links
Texas State Tests Potential New Cancer-Fighting Weapon
Date:10/12/2009

SAN MARCOS, Texas, Oct. 12 /PRNewswire/ -- Researchers at Texas State University-San Marcos have completed initial testing of a cancer chemotherapeutic and anti-retroviral compound with promising results.

Dhiraj Vattem, professor in the Department of Family and Consumer Sciences, and Reed Richardson, professor in the Department of Agriculture, supervised the tests in cooperation with Orizon Research. Results were announced at a University press conference.

The product, known as ALKA-V6, is a proprietary modified silicon-based compound developed by Orizon Research. The in-vitro evaluations will be followed by a second phase of testing for ALKA-V6 which will consist of end-point evaluations in in-vivo systems. Results from second-phase testing are expected within the next 12 months.

The anticancer studies revealed ALKA-V6:

  • prevented attachment of cancer cells
  • (a 1:40 dilution) completely killed all colon cancer cells (100% lethality)
  • reduced harmful mutations in the DNA
  • induced apoptosis (programmed cell death)
  • stimulated important antioxidant enzymes

The anti-retroviral studies revealed ALKA-V6:

  • increased nitric oxide dependent anti-viral effects
  • inhibited enzymes important in viral assembly, metabolism, and replication
  • caused changes in the surface carbohydrate composition and metabolism
  • inhibited the activity of the enzyme responsible for reverse transcription

The unique electrochemical and structural composition of ALKA-V6 indicates that it may provide an alternative basis for control of cancer cell growth and virus survival. However, this implication is based solely on in-vitro results and end-point in-vivo evaluations are imperative.

Orizon Research Institute of Odessa, Texas is the international distributor of ALKA V-6, which is currently being sold as a nutritional supp
'/>"/>

SOURCE Orizon Research Institute
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Three Surgeons in East Texas Are Successfully Integrating a Novel Stem Cell Procedure for Spine Surgeries
2. Cancer Therapy & Research Center at The University of Texas Health Science Center and Oncolytics Biotech(R) Inc. Announce Multi-Trial Clinical Research Collaboration
3. WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System
4. Texas Back Institute Leads Way in New Facet Joint Clinical Trial
5. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation
6. Caliper Life Sciences Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center
7. Texas Heart(R) Institute at St. Lukes Episcopal Hospital Initiates First Clinical Trial in the World to Treat a Heart Attack Patient with a Special Stem Cell Type
8. Vical Receives NIH Grant for an Immunotherapeutic Herpes DNA Vaccine; Herpes Experts at University of Washington and University of Texas to Conduct Preclinical Development
9. Iowas Largest Health System Launches First-in-the-Nation Statewide Electronic Prescribing
10. ProUroCare Medical Completes Multiple Site Clinical Study for Imaging Prostate Abnormalities
11. Newly Updated Pharmacy State Law Compendium Available
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Dec. 4 Vermillion, Inc. (VRML) (Pink Sheets: VRMLQ) announced ... Plan of Reorganization and related amended Disclosure Statement with the ... ,, A hearing to consider the adequacy of the ... the hearing on the confirmation of the Plan scheduled for ...
(Date:12/4/2009)... Amber Pharmacy announced today that it received accreditation ... for specialized pharmacy services. For nearly 15 years, Amber ... to meet the unique needs of specialized conditions. Amber ... to transplant programs. They work with over 170 transplant ...
(Date:12/4/2009)... Dec. 4 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: ... enrolled in the company,s Phase II-b, dose escalation, clinical ... traumatic brain injury (TBI). Oxycyte is the Company,s perfluorocarbon ... invaluable importance in improving the outcome of patients with ...
Breaking Medicine Technology:Vermillion Files Amended Plan of Reorganization and Exchanges Debt 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 3Amber Pharmacy Earns Accreditation From ACHC 2Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2The Rasansky Law Firm Announces Dallas Day Care Death Lawsuit 3B State Investigation Finds Evidence of Negligence at Woodbridge Day School 60768 1The Rasansky Law Firm Announces Dallas Day Care Death Lawsuit 3B State Investigation Finds Evidence of Negligence at Woodbridge Day School 60768 2Working Parents Take the Panic Out of Flu Pandemic 60763 1Working Parents Take the Panic Out of Flu Pandemic 60763 2WaferGen Names Christopher Sears Ph D Architect of High Value Molecular Diagnostics and Computational Biology Platforms to Companys Scientific Adv 14734 1WaferGen Names Christopher Sears Ph D Architect of High Value Molecular Diagnostics and Computational Biology Platforms to Companys Scientific Adv 14734 2WaferGen Names Christopher Sears Ph D Architect of High Value Molecular Diagnostics and Computational Biology Platforms to Companys Scientific Adv 14734 3WaferGen Names Christopher Sears Ph D Architect of High Value Molecular Diagnostics and Computational Biology Platforms to Companys Scientific Adv 14734 4
(Date:12/6/2009)... new study provides welcome news for patients with a ... , The condition is estimated to impact 62,000 Canadians ... abnormal clot forms in a vein and restricts the ... cases, the clot may detach from its point of ... causing a potentially fatal condition known as a pulmonary ...
(Date:12/5/2009)... significant scientific advances in the field of blood cancers, ... of how certain diseases progress in order to discover ... care. Research presented today at the 51st Annual Meeting ... therapies for managing multiple myeloma, the importance of advance ...
(Date:12/5/2009)... , , SATURDAY, Dec. 5 (HealthDay News) -- They,re not ... bad reactions to certain holiday traditions and need to ... to the American College of Allergy, Asthma and Immunology ... may choose to decorate with artificial plants, but both ...
(Date:12/5/2009)... most unusual places, and to do everything from growing mushrooms, making wine ... ... Who would have thought that your wine, water and vegetables would have ... a new line of turbines, for industry end users, not wind farms. ...
(Date:12/4/2009)... Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd ... Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive ... at the 2009,Goldman Sachs U.S. Financial Services Conference being ... City on Tuesday, December 8, 2009. ,, ...
Breaking Medicine News(10 mins):Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2
... WOONSOCKET, R.I., Feb. 4 CVS Caremark (NYSE: ... Caremark Customer Care Centers have again been recognized ... Associates Certified Call Center Program(SM). This is the ... distinction, which acknowledges Caremark,s call center operations as ...
... Americas, Inc., an international,leader in mouth and body ... Group Limited to demonstrate consumers, desires to purchase,products ... The 1,957 people who participated in ... asked about their relationship with their dental hygienist;,the ...
... 4 Dr. Xavier Azar is proud to present his ... published by AuthorHouse ), a highly educational book for parents ... after birth and continuing on through one,s adult life."When the ... care preventive therapies as well as informing the masses about ...
... functional decline, could ward off osteoarthritis, study says ... Exercise may play a key role in helping ... osteoarthritis (OA), two new studies show. , , After ... six-week progressive strengthening program showed much improvement in ...
... while expert notes exercise best antidote , , WEDNESDAY, Feb. 4 (HealthDay ... of a heart attack in middle-aged women, a new study finds. ... associated with a higher risk for heart attack," said Dr. Judith ... issue of BMJ . "Until now, that data has been ...
... The Blue Foundation for a Healthy Florida ... Shield of Florida (BCBSF), recently approved $499,418 for grants ... epidemic,s impact on children and health care in Florida. ... physical activity.The grants are part of The Blue Foundation,s ...
Other Medicine News:Health News:Caremark Customer Care Centers Recognized for Customer Satisfaction Excellence by J.D. Power and Associates Certified Call Center Program(SM) 2Health News:Study Reveals Consumers Want to Buy Products That Dental Hygienists Recommend 2Health News:'When the Tooth Fairy is Not Enough': A Collection of the Most Common Misconceptions in Oral Health Care Set in a Parent-Friendly Book 2Health News:Exercise Key Player in Knee Replacement Recovery 2Health News:High Resting Heart Rate Spells Trouble for Women 2Health News:Embrace a Healthy Florida Pumps Up Studies on Childhood Obesity 2Health News:Embrace a Healthy Florida Pumps Up Studies on Childhood Obesity 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: